1-3 of 3
Jo White
Close
Sort by
Journal Articles

A Novel Bayesian Prognostic Index for Diffuse Large B-Cell Lymphoma: A New Powerful Tool for Prediction of Outcome.

Michal Sieniawski, MD, Malcolm Farrow, Xiao Zhao, Jennifer Wilkinson, Tryfonia Mainou-Fowler, Jo White, John MacIntyre, Stephen J. Proctor
Journal: Blood
Blood (2009) 114 (22): 1666.
https://doi.org/10.1182/blood.V114.22.1666.1666
Published: 2009
Journal Articles

Duration of First Remission in Diffuse Large B-Cell Lymphoma (DLBCL) Define Groups of Patients with Different Overall Survival Which Cannot Be Entirely Distinguished by Clinical Features or IPI at Diagnosis: a Prospective Population Based Study of the Scotland and Newcastle Lymphoma Group

Michal Sieniawski, Jennifer Wilkinson, Dominic Culligan, John Davies, John Goodlad, Ruth Jarrett, Anne L Lennard, Helen Lucraft, Tryfonia Mainou-Fowler, Pam McKay, Fiona Scott, Sudhir Tauro, Jo White, Stephen J Proctor
Journal: Blood
Blood (2008) 112 (11): 2604.
https://doi.org/10.1182/blood.V112.11.2604.2604
Published: 2008
Journal Articles

Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: a population-based study

Clinical Trials & Observations
Ruth F. Jarrett, Gail L. Stark, Jo White, Brian Angus, Freda E. Alexander, Andrew S. Krajewski, June Freeland, G. Malcolm Taylor, Penelope R. A. Taylor, for the Scotland and Newcastle Epidemiology of Hodgkin Disease Study Group
Journal: Blood
Blood (2005) 106 (7): 2444–2451.
https://doi.org/10.1182/blood-2004-09-3759
Published: 2005